Log In
Print
BCIQ
Print
Print this Print this
 

AdVac tuberculosis vaccine (AERAS-402/Crucell Ad35)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionTuberculosis vaccine based on adenovirus serotype 35
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsVaccinate against tuberculosis (TB); Vaccinate infants against tuberculosis
Regulatory Designation

Partner

Aeras Global TB Vaccine Foundation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today